Managed IT for Life Sciences
the lab data survives the FDA audit or the batch doesn't ship.
Life sciences IT across SoCal — biotech, pharma, medical device, CROs, diagnostic labs, academic research. 21 CFR Part 11. GxP. LabWare LIMS. Benchling ELN. Veeva Vault. IDBS. Validated systems. FDA audit-ready.
Managed IT for life sciences — the regulatory bar sits above everything else
Life sciences IT operates under a compliance framework that treats every system touching regulated data as a validated system. 21 CFR Part 11 defines electronic records and signatures requirements. GxP (GLP, GCP, GMP) sets the operational discipline. FDA data integrity guidance (ALCOA+) makes it enforceable.
The scope: validated system operations under 21 CFR Part 11, LIMS platform support (LabWare, LabVantage, Thermo Fisher SampleManager, STARLIMS), ELN platform support (Benchling, IDBS E-WorkBook, LabArchives), QMS / eQMS support (Veeva Vault, MasterControl, TrackWise), lab instrument connectivity, GxP-aware backup and DR, and FDA audit-ready documentation across all systems.
Pairs with managed services for core operations, HIPAA compliance for patient-touching systems, networking for lab connectivity, and clean-room infrastructure for controlled environments. Start with a free assessment.
Three patterns that lead to Form 483 findings
FDA Form 483 observations frequently trace back to IT-adjacent gaps. The remediation costs multiples of what prevention would have.
Audit trails have gaps
System audit trails need to be immutable, time-stamped, attributable, and complete under 21 CFR Part 11. Most systems ship with audit trail enabled but not validated against actual regulatory requirements. Gaps show up during FDA audit. Validated audit trail configuration and periodic review closes the gap.
Backup restoration was never tested against GxP
Backups run nightly. Nobody has restored a full LIMS or ELN to a validated state under GxP protocols. When the disaster happens or the auditor asks, the restoration is unproven. Documented GxP-aware restore testing on a validation schedule is the answer.
Change control is generic IT change control
Standard IT change control (approve, schedule, execute, verify) is not GxP change control. Validated systems require impact assessment, validation planning, protocol execution, and requalification. The IT team follows their process; the QA team follows theirs; the middle stays undocumented. Integrated change control is what closes the gap.
Why choose WCC for managed IT for life sciences
Life sciences IT is validated systems + LIMS / ELN / QMS operations + GxP infrastructure + audit-ready documentation + integrated change control. WCC handles all five.
CSLB C-7 · C-10 · C-28
Active California contractor license. Lab infrastructure, clean-room adjacent work, structured cabling under one license stack. Permits handled.
LabWare · Benchling · Veeva
LIMS, ELN, and QMS platform operations. LabWare, LabVantage, SampleManager, STARLIMS, Benchling, IDBS, Veeva Vault, MasterControl, TrackWise.
Part 11 Validated Systems
Validated system operations under 21 CFR Part 11. Audit trail integrity. Electronic signature enforcement. System validation documentation. Requalification support.
Change Control + Documentation
Integrated GxP change control aligned to customer QA / RA. FDA audit-ready documentation. Data integrity (ALCOA+) operational discipline. Form 483 remediation experience.
The six life sciences IT capability areas
Each capability scopes to research phase, regulatory posture, and existing validation baseline.
LIMS Platform Operations
LabWare, LabVantage, Thermo Fisher SampleManager, STARLIMS platform operations. Sample tracking workflow. Instrument integration. Configuration management under validation.
ELN Platform Operations
Benchling, IDBS E-WorkBook, LabArchives, Dotmatics electronic lab notebook operations. User provisioning under GxP. Template management. Search and retrieval optimization.
QMS / eQMS Operations
Veeva Vault QMS, MasterControl, TrackWise, ETQ Reliance electronic quality management. Document control workflow. Training records. CAPA and deviation tracking.
21 CFR Part 11 Compliance
Validated system operations. Audit trail integrity verification. Electronic signature enforcement. Periodic requalification. System validation documentation maintenance. IQ / OQ / PQ record retention.
Lab Instrument Connectivity
HPLC, GC, mass spec, plate reader, sequencer, and other lab instrument connectivity. Instrument data acquisition to LIMS / ELN. Firmware management. Calibration records integration.
GxP-Aware Backup + DR
Backup strategy aligned to GxP data retention. Documented restore testing under validation protocols. DR planning with regulatory-aware RTO / RPO. Disaster recovery documentation for audits.
Life-sci IT — common questions
Validated system operations under 21 CFR Part 11, LIMS platform support (LabWare, LabVantage, SampleManager, STARLIMS), ELN platform support (Benchling, IDBS, LabArchives), QMS / eQMS support (Veeva Vault, MasterControl, TrackWise), lab instrument connectivity, GxP-aware backup and disaster recovery, and FDA audit-ready documentation across all systems. Plus standard managed IT.
Systems that create, modify, maintain, archive, retrieve, or transmit regulated electronic records must have validated access controls, audit trails (immutable, time-stamped, attributable), electronic signature enforcement, and documented validation. Every system component in the regulated data path is in scope. Managed operations include ongoing validation state maintenance and audit-trail integrity verification.
Integrated change control. IT change requests are impact-assessed against validated systems. Changes affecting validated systems trigger the customer's QA change control process. Validation planning, protocol execution, and requalification happen under QA ownership with WCC executing the technical work. Documentation lands in the customer's QMS. QA remains the compliance owner.
Clean-room infrastructure (ISO 14644 classified environments, aseptic manufacturing, and GMP-controlled areas) has its own set of IT requirements: environmental monitoring integration, personnel access tracking, garmenting-station workflow support, and clean-room-compatible endpoints. WCC operations include coordination with facilities and QA for controlled environment IT changes.
Ongoing audit readiness rather than pre-audit cramming. System validation documentation stays current. Audit trail integrity is verified periodically. Change control records land in the QMS at the time of change. When the FDA inspector arrives, the documentation package is ready. Form 483 remediation experience means WCC understands what auditors actually look for.
Early-stage biotech (under 50 users, single site): $200-400 per user per month all-in including validated systems support. Growth-stage biotech (50-250 users, multi-site with GMP): $250-500 per user per month plus platform-specific ops. Commercial-stage pharma or medical device (250+ users, full GxP scope): $300-650 per user per month plus dedicated compliance operations. Multi-year contracts with defined validation events discount pricing.
Regulated life-sci IT pairs with these capabilities
Regulated operations depend on the surrounding compliance, network, and clean-room infrastructure.
Life sciences IT across Southern California
WCC supports biotech and pharma IT across all six SoCal counties — medical device, CROs, diagnostic labs, academic research. San Diego biotech corridor. Chino HQ.
Life sciences IT is validated systems operated under a compliance framework.
WCC delivers life sciences IT: 21 CFR Part 11 validated system operations, LIMS support across LabWare / LabVantage / SampleManager, ELN support across Benchling / IDBS / LabArchives, QMS support across Veeva Vault / MasterControl, lab instrument connectivity, GxP-aware backup and DR, and FDA audit-ready documentation. CSLB C-7 / C-10 / C-28.
